文献速递帕金森病与运动障碍

活动记录仪助力帕金森病快速眼动睡眠行为障碍的家庭筛查

Actigraphy Enables Home Screening of Rapid Eye Movement Behavior Disorder in Parkinson's Disease.
PubMed 文献 · Ann Neurol · 2022-10-20

研究纳入26例帕金森病患者,进行2周家庭腕部活动记录仪监测及两次实验室评估,基于梦境演绎史和视频多导睡眠图分为快速眼动睡眠行为障碍(RBD)组与非RBD组。利用活动记录信号提取运动特征并训练机器学习分类算法,在实验室测试中准确率达92.9±8.16%,在2周家庭记录中准确率达100%,在非帕金森病其他睡眠疾病对照组中准确率为94.4%。

要点

  • 基于活动记录仪的运动特征可自动分类帕金森病患者的快速眼动睡眠行为障碍。
  • 分类算法在实验室测试中准确率为92.9±8.16%,在家庭记录中准确率达100%。
  • 在非帕金森病其他睡眠疾病对照组中验证准确率为94.4%。

核心结论

  • 活动记录仪结合机器学习分类算法有望实现更快速、更廉价且更规律的睡眠障碍筛查,适用于常规临床实践和临床试验。

研究设计与样本

  • 研究纳入26例帕金森病患者,进行2周家庭腕部活动记录仪监测,随后进行两次实验室评估。
  • 根据梦境演绎史和视频多导睡眠图将患者分为快速眼动睡眠行为障碍(RBD)组与非RBD组。
  • 利用活动记录信号提取运动特征,训练机器学习分类算法以区分有无RBD,并在非帕金森病其他睡眠疾病对照组中进一步验证性能。

主要发现

  • RBD患者总体活动更多,运动持续时间更短、幅度更高且时间上更分散。
  • 分类算法在实验室测试中准确率为92.9±8.16%。
  • 在帕金森病患者家庭记录中,2周窗口内准确率达100%。
  • 在非帕金森病其他睡眠疾病对照组中准确率为94.4%。
  • 特征在各项测试和条件下表现出稳健性。

临床怎么用

  • 原文结论指出,这些结果为更快速、更廉价且更规律的睡眠障碍筛查开辟了新视角,适用于常规临床实践和临床试验。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Rapid eye movement sleep behavior disorder (RBD) is a potentially harmful, often overlooked sleep disorder affecting up to 70% of Parkinson's disease patients. Current diagnosis relies on nocturnal video-polysomnography, which is an expensive and cumbersome examination requiring specific clinical expertise. Here, we explored the use of wrist actigraphy to enable automatic RBD diagnoses in home settings. METHODS: A total of 26 Parkinson's disease patients underwent 2-week home wrist actigraphy, followed by two in-laboratory evaluations. Patients were classified as RBD versus non-RBD based on dream enactment history and video-polysomnography. We comprehensively characterized patients' movement patterns during sleep using actigraphic signals. We then trained machine learning classification algorithms to discriminate patients with or without RBD using the most relevant features. Classification performance was quantified with respect to clinical diagnosis, separately for in-laboratory and at-home recordings. Performance was further validated in a control group of non-Parkinson's disease patients with other sleep conditions. RESULTS: To characterize RBD, actigraphic features extracted from both (1) individual movement episodes and (2) global nocturnal activity were critical. RBD patients were more active overall, and showed movements that were shorter, of higher magnitude, and more scattered in time. Using these features, our classification algorithms reached an accuracy of 92.9 ± 8.16% during in-clinic tests. When validated on home recordings in Parkinson's disease patients, accuracy reached 100% over a 2-week window, and was 94.4% in non-Parkinson's disease control patients. Features showed robustness across tests and conditions. INTERPRETATION: These results open new perspectives for faster, cheaper, and more regular screening of sleep disorders, both for routine clinical practice and clinical trials. ANN NEUROL 2023;93:317-329.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Raschellà F, Scafa S, Puiatti A, et al. Actigraphy Enables Home Screening of Rapid Eye Movement Behavior Disorder in Parkinson's Disease. Ann Neurol. 2022. PMID: 36193943. doi:10.1002/ana.26517

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。